Vaccination of pregnant rhesus monkeys with inactivated rotavirus as a model for achieving protection from rotavirus SA11 infection in the offspring

References

• Crawford SE, Ramani S, Tate JE, Parashar UD, Svensson L, Hagbom M, Franco MA, Greenberg HB, O’Ryan M, Kang G, et al. Rotavirus infection. Nat Rev Dis Primers. 2017;3(1):17083. doi:10.1038/nrdp.2017.83 .
   PubMed Web of Science ®Google Scholar
• Sadiq A, Bostan N, Yinda KC, Naseem S, Sattar S. Rotavirus: genetics, pathogenesis and vaccine advances. Rev Med Virol. 2018;28:e2003. doi:10.1002/rmv.2003 .
   PubMed Web of Science ®Google Scholar
• Matthijnssens J, Ciarlet M, Rahman M, Attoui H, Banyai K, Estes MK, Gentsch JR, Iturriza-Gómara M, Kirkwood CD, Martella V, et al. Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol. 2008;153(8):1621–29. doi:10.1007/s00705-008-0155-1 .
   PubMed Web of Science ®Google Scholar
• https://rega.kuleuven.be/cev/viralmetagenomics/virus-classification/rcwg .
   Google Scholar
• Bulut Y, Yenisehirli G, Durmaz R. Molecular epidemiology of rotavirus strains in under five children. Indian J Pediatr. 2018;85:364–68. doi:10.1007/s12098-017-2540-9 .
   PubMed Web of Science ®Google Scholar
• Tavakoli Nick S, Mohebbi SR, Ghaemi A, Hosseini SM. Human rotavirus in Iran; molecular epidemiology, genetic diversity and recent updates on vaccine advances. Gastroenterol Hepatol Bed Bench. 2019;12:98–109 .
   PubMedGoogle Scholar
• Li W, Xiang W, Li C, Xu J, Zhou D, Shang S. Molecular epidemiology of rotavirus A and adenovirus among children with acute diarrhea in Hangzhou, China. Gut Pathog. 2020;12(1):19. doi:10.1186/s13099-020-00359-4 .
   PubMed Web of Science ®Google Scholar
• Leung AK, Robson WL. Acute gastroenteritis in children: role of anti-emetic medication for gastroenteritis-related vomiting. Paediatr Drugs. 2007;9(3):175–84. doi:10.2165/00148581-200709030-00006 .
   PubMedGoogle Scholar
• Yen C, Tate JE, Patel MM, Cortese MM, Lopman B, Fleming J, Lewis K, Jiang B, Gentsch JR, Steele AD, et al. Rotavirus vaccines: update on global impact and future priorities. Hum Vaccin. 2011;7(12):1282–90. doi:10.4161/hv.7.12.18321 .
   PubMed Web of Science ®Google Scholar
• Patton JT. Rotavirus diversity and evolution in the post-vaccine world. Discov Med. 2012;13:85–97 .
   PubMed Web of Science ®Google Scholar
• Burnett E, Parashar UD, Tate JE. Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis. Lancet Glob Health. 2020;8:e1195–e202. doi:10.1016/S2214-109X(20)30262-X .
   PubMed Web of Science ®Google Scholar
• Burke RM, Tate JE, Kirkwood CD, Steele AD, Parashar UD. Current and new rotavirus vaccines. Curr Opin Infect Dis. 2019;32:435–44. doi:10.1097/QCO.0000000000000572 .
   PubMed Web of Science ®Google Scholar
• Soares-Weiser K, Bergman H, Henschke N, Pitan F, Cunliffe N. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2019;3:CD008521. doi:10.1002/14651858.CD008521.pub4 .
   PubMedGoogle Scholar
• Tate JE, Burton AH, Boschi-Pinto C, Parashar UD; World Health Organization-Coordinated Global Rotavirus Surveillance N. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000-2013. Clin Infect Dis. 2016;62(Suppl 2):S96–S105. doi:10.1093/cid/civ1013 .
   PubMed Web of Science ®Google Scholar
• Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9:565–72. doi:10.3201/eid0905.020562 .
   PubMed Web of Science ®Google Scholar
• Li J, Zhang Y, Yang Y, Liang Z, Tian Y, Liu B, Gao Z, Jia L, Chen L, Wang Q, et al. Effectiveness of Lanzhou lamb rotavirus vaccine in preventing gastroenteritis among children younger than 5 years of age. Vaccine. 2019;37:3611–16. doi:10.1016/j.vaccine.2019.03.069 .
   PubMed Web of Science ®Google Scholar
• Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, Armah G, Bines JE, Brewer TG, Colombara DV, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172:958–65. doi:10.1001/jamapediatrics.2018.1960 .
   PubMed Web of Science ®Google Scholar
• Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382:209–22. doi:10.1016/S0140-6736(13)60844-2 .
   PubMed Web of Science ®Google Scholar
• Otero CE, Langel SN, Blasi M, Permar SR. Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries. PLoS Pathog. 2020;16:e1009010. doi:10.1371/journal.ppat.1009010 .
   PubMed Web of Science ®Google Scholar
• Desselberger U. Differences of rotavirus vaccine effectiveness by country: likely causes and contributing factors. Pathogens. 2017;6:65. doi:10.3390/pathogens6040065 .
   PubMed Web of Science ®Google Scholar
• Parker EP, Ramani S, Lopman BA, Church JA, Iturriza-Gomara M, Prendergast AJ, Grassly NC. Causes of impaired oral vaccine efficacy in developing countries. Future Microbiol. 2018;13:97–118. doi:10.2217/fmb-2017-0128 .
   PubMed Web of Science ®Google Scholar
• Reddy SN, Nair NP, Tate JE, Thiyagarajan V, Giri S, Praharaj I, Mohan VR, Babji S, Gupte MD, Arora R. Intussusception after Rotavirus Vaccine Introduction in India. N Engl J Med. 2020;383(20):1932–40. doi:10.1056/NEJMoa2002276 .
   PubMed Web of Science ®Google Scholar
• Group IISNS. Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: a self-controlled case series analysis. Vaccine. 2021;39:78–84. doi:10.1016/j.vaccine.2020.09.019 .
   PubMed Web of Science ®Google Scholar
• Huang WT, Juan YC, Liu CH, Yang YY, Chan KA. Intussusception and Kawasaki disease after rotavirus vaccination in Taiwanese infants. Vaccine. 2020;38:6299–303. doi:10.1016/j.vaccine.2020.07.038 .
   PubMed Web of Science ®Google Scholar
• Yin S, Liubao P, Chongqing T, Xiaomin W. The first case of Kawasaki disease in a 20-month old baby following immunization with rotavirus vaccine and hepatitis A vaccine in China: a case report. Hum Vaccin Immunother. 2015;11:2740–43. doi:10.1080/21645515.2015.1050571 .
   PubMed Web of Science ®Google Scholar
• Offit PA. Challenges to developing a rotavirus vaccine. Viral Immunol. 2018;31:104–08. doi:10.1089/vim.2017.0121 .
   PubMed Web of Science ®Google Scholar
• Burnett E, Parashar U, Tate J. Rotavirus vaccines: effectiveness, safety, and future directions. Paediatr Drugs. 2018;20:223–33. doi:10.1007/s40272-018-0283-3 .
   PubMed Web of Science ®Google Scholar
• Jiang B, Estes MK, Barone C, Barniak V, O’Neal CM, Ottaiano A, Madore HP, Conner ME. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles. Vaccine. 1999;17:1005–13. doi:10.1016/S0264-410X(98)00317-X .
   PubMed Web of Science ®Google Scholar
• Crawford SE, Estes MK, Ciarlet M, Barone C, O’Neal CM, Cohen J, Conner ME. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles. J Virol. 1999;73(6):4813–22. doi:10.1128/JVI.73.6.4813-4822.1999 .
   PubMed Web of Science ®Google Scholar
• Blutt SE, Warfield KL, O’Neal CM, Estes MK, Conner ME. Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs). Vaccine. 2006;24(8):1170–79. doi:10.1016/j.vaccine.2005.08.090 .
   PubMed Web of Science ®Google Scholar
• Liu GF, Hille D, Kaplan SS, Goveia MG. Postdose 3 G1 serum neutralizing antibody as correlate of protection for pentavalent rotavirus vaccine. Hum Vaccin Immunother. 2017;13(10):2357–63. doi:10.1080/21645515.2017.1356522 .
   PubMed Web of Science ®Google Scholar
• Velazquez FR, Matson DO, Guerrero ML, Shults J, Calva JJ, Morrow AL, Glass R, Pickering L, Ruiz‐Palacios G. Serum antibody as a marker of protection against natural rotavirus infection and disease. J Infect Dis. 2000;182(6):1602–09. doi:10.1086/317619 .
   PubMed Web of Science ®Google Scholar
• Nair N, Feng N, Blum LK, Sanyal M, Ding S, Jiang B, Sen A, Morton JM, He X-S, Robinson WH. VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans. Sci Transl Med. 2017;9(395):eaam5434. doi:10.1126/scitranslmed.aam5434 .
   PubMed Web of Science ®Google Scholar
• Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM, et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med. 1996;335(14):1022–28. doi:10.1056/NEJM199610033351404 .
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11–22. doi:10.1056/NEJMoa052434 .
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007;370(9601):1757–63. doi:10.1016/S0140-6736(07)61744-9 .
   PubMed Web of Science ®Google Scholar
• Steele AD, Neuzil KM, Cunliffe NA, Madhi SA, Bos P, Ngwira B, Witte D, Todd S, Louw C, Kirsten M, et al. Human rotavirus vaccine Rotarix provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis. 2012;12:213. doi:10.1186/1471-2334-12-213 .
   PubMed Web of Science ®Google Scholar
• Yin N, Yang FM, Qiao HT, Zhou Y, Duan SQ, Lin XC, Wu J-Y, Xie Y-P, He Z-L, Sun M-S, et al. Neonatal rhesus monkeys as an animal model for rotavirus infection. World J Gastroenterol. 2018;24:5109–19. doi:10.3748/wjg.v24.i45.5109 .
   PubMed Web of Science ®Google Scholar
• Boshuizen JA, Reimerink JH, Korteland-van Male AM, van Ham VJ, Koopmans MP, Buller HA, Dekker J, Einerhand AWC. Changes in small intestinal homeostasis, morphology, and gene expression during rotavirus infection of infant mice. J Virol. 2003;77:13005–16. doi:10.1128/JVI.77.24.13005-13016.2003 .
   PubMed Web of Science ®Google Scholar
• Li JT, Wei J, Guo HX, Han JB, Ye N, He HY, Yu -T-T, Wu Y-Z. Development of a human rotavirus induced diarrhea model in Chinese mini-pigs. World J Gastroenterol. 2016;22:7135–45. doi:10.3748/wjg.v22.i31.7135 .
   PubMed Web of Science ®Google Scholar
• Rha B, Tate JE, Payne DC, Cortese MM, Lopman BA, Curns AT, Parashar UD. Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012. Expert Rev Vaccines. 2014;13:365–76. doi:10.1586/14760584.2014.877846 .
   PubMed Web of Science ®Google Scholar
• Jonesteller CL, Burnett E, Yen C, Tate JE, Parashar UD. Effectiveness of Rotavirus Vaccination: a Systematic Review of the First Decade of Global Postlicensure Data, 2006-2016. Clin Infect Dis. 2017;65:840–50. doi:10.1093/cid/cix369 .
   PubMed Web of Science ®Google Scholar
• Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):606–14. doi:10.1016/S0140-6736(10)60889-6 .
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362:289–98. doi:10.1056/NEJMoa0904797.
   PubMed Web of Science ®Google Scholar
• Resch TK, Wang Y, Moon SS, Joyce J, Li S, Prausnitz M, Jiang, B. Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice. Sci Rep. 2018;8:561. doi:10.1038/s41598-017-18973-9.
   PubMed Web of Science ®Google Scholar
• Groome MJ, Fairlie L, Morrison J, Fix A, Koen A, Masenya M, Jose, L, Madhi, SA, Page, N, McNeal, M, et al. Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2020;20:851–63. doi:10.1016/S1473-3099(20)30001-3.
   PubMed Web of Science ®Google Scholar
• Wang Y, Azevedo M, Saif LJ, Gentsch JR, Glass RI, Jiang B. Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets. Vaccine. 2010;28:5432–36 .
   PubMed Web of Science ®Google Scholar
• Clarke E, Desselberger U. Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol. 2015;8:1–17. doi:10.1038/mi.2014.114 .
   PubMed Web of Science ®Google Scholar
• Angel J, Franco MA, Greenberg HB. Rotavirus immune responses and correlates of protection. Curr Opin Virol. 2012;2:419–25. doi:10.1016/j.coviro.2012.05.003 .
   PubMed Web of Science ®Google Scholar
• Caddy SL, Vaysburd M, Wing M, Foss S, Andersen JT, O’Connell K, Mayes K, Higginson K, Iturriza-Gómara M, Desselberger U, et al. Intracellular neutralisation of rotavirus by VP6-specific IgG. PLoS Pathog. 2020;16:e1008732. doi:10.1371/journal.ppat.1008732 .
   PubMed Web of Science ®Google Scholar
• Snodgrass DR. Development of calf diarrhoea vaccines. Ann Rech Vet. 1983;14:519–21 .
   PubMedGoogle Scholar
• Castrucci G, Frigeri F, Angelillo V, Ferrari M, Cilli V, Aldrovandi V. Field trial evaluation of an inactivated rotavirus vaccine against neonatal diarrhea of calves. Eur J Epidemiol. 1987;3:5–9. doi:10.1007/BF00145064 .
   PubMedGoogle Scholar
• Powell DG, Dwyer RM, Traub-Dargatz JL, Fulker RH, Whalen JW Jr., Srinivasappa J, Acree, WM, Chu, HJ. Field study of the safety, immunogenicity, and efficacy of an inactivated equine rotavirus vaccine. J Am Vet Med Assoc. 1997;211:193–98.
   PubMed Web of Science ®Google Scholar
• Nemoto M, Inagaki M, Tamura N, Bannai H, Tsujimura K, Yamanaka T, Kokado, H. Evaluation of inactivated vaccines against equine group A rotaviruses by use of a suckling mouse model. Vaccine. 2018;36:5551–55. doi:10.1016/j.vaccine.2018.07.057.
   PubMed Web of Science ®Google Scholar